Noble E. Jarrell

Array ( [id] => 8408674 [patent_doc_number] => RE043688 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2012-09-25 [patent_title] => 'Compositions and methods related to serotonin 5-HT1A receptors' [patent_app_type] => reissue [patent_app_number] => 13/187728 [patent_app_country] => US [patent_app_date] => 2011-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 9279 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13187728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8571831 [patent_doc_number] => 08338478 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-25 [patent_title] => 'Derivatives of 3,3-diphenylpropylamines' [patent_app_type] => utility [patent_app_number] => 13/161049 [patent_app_country] => US [patent_app_date] => 2011-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 20630 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13161049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8733941 [patent_doc_number] => 20130079510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-28 [patent_title] => 'CYCLIC CARBODIIMIDE COMPOUND' [patent_app_type] => utility [patent_app_number] => 13/702429 [patent_app_country] => US [patent_app_date] => 2011-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17757 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13702429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8815384 [patent_doc_number] => 20130116429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-09 [patent_title] => 'Gadobutrol Preparation in a One-Pot Process by means of DMF Acetal and N-Methylimidazole' [patent_app_type] => utility [patent_app_number] => 13/701914 [patent_app_country] => US [patent_app_date] => 2011-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1731 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13701914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12326208 [patent_doc_number] => 09944722 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-17 [patent_title] => Chelator and use thereof [patent_app_type] => utility [patent_app_number] => 13/701074 [patent_app_country] => US [patent_app_date] => 2011-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9467 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13701074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9127233 [patent_doc_number] => 08575182 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-05 [patent_title] => '6, 9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions' [patent_app_type] => utility [patent_app_number] => 13/116725 [patent_app_country] => US [patent_app_date] => 2011-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17569 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13116725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11198322 [patent_doc_number] => 09428524 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-30 [patent_title] => 'Synthetic process for the manufacture of ecteinascidin compounds' [patent_app_type] => utility [patent_app_number] => 13/699052 [patent_app_country] => US [patent_app_date] => 2011-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17041 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13699052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8689978 [patent_doc_number] => 08389505 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-05 [patent_title] => 'Adamantane derivatives of AZA-crown ethers and their use in treatment of tumor' [patent_app_type] => utility [patent_app_number] => 13/107492 [patent_app_country] => US [patent_app_date] => 2011-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6319 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13107492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8104077 [patent_doc_number] => 08153683 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-10 [patent_title] => 'Methods of treatment using a prodrug of an excitatory amino acid' [patent_app_type] => utility [patent_app_number] => 13/100642 [patent_app_country] => US [patent_app_date] => 2011-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48982 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/153/08153683.pdf [firstpage_image] =>[orig_patent_app_number] => 13100642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9086351 [patent_doc_number] => 08557780 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-15 [patent_title] => 'Monomethylvaline compounds capable of conjugation to ligands' [patent_app_type] => utility [patent_app_number] => 13/098393 [patent_app_country] => US [patent_app_date] => 2011-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 43 [patent_no_of_words] => 80714 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13098393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9009441 [patent_doc_number] => 08524739 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-03 [patent_title] => 'Quinoline derivatives and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/093261 [patent_app_country] => US [patent_app_date] => 2011-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17810 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13093261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9503571 [patent_doc_number] => 08741884 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-03 [patent_title] => 'Compounds for the treatment of hepatitis C' [patent_app_type] => utility [patent_app_number] => 13/086704 [patent_app_country] => US [patent_app_date] => 2011-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31228 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13086704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6168380 [patent_doc_number] => 20110196147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'INHIBITORS OF HISTONE DEACETYLASE' [patent_app_type] => utility [patent_app_number] => 13/079458 [patent_app_country] => US [patent_app_date] => 2011-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 107590 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20110196147.pdf [firstpage_image] =>[orig_patent_app_number] => 13079458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10613842 [patent_doc_number] => 09333269 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-10 [patent_title] => 'Polyplex gene delivery vectors' [patent_app_type] => utility [patent_app_number] => 13/635640 [patent_app_country] => US [patent_app_date] => 2011-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 7815 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13635640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8049223 [patent_doc_number] => 20120074336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'LIGHT-DRIVEN ROTARY MOLECULAR MOTORS' [patent_app_type] => utility [patent_app_number] => 13/051439 [patent_app_country] => US [patent_app_date] => 2011-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 21131 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20120074336.pdf [firstpage_image] =>[orig_patent_app_number] => 13051439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10026067 [patent_doc_number] => 09067953 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-30 [patent_title] => 'Systems for carbon dioxide and sulfur dioxide removal' [patent_app_type] => utility [patent_app_number] => 13/045578 [patent_app_country] => US [patent_app_date] => 2011-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6175 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13045578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6016853 [patent_doc_number] => 20110224229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'Novel Crystalline Form' [patent_app_type] => utility [patent_app_number] => 13/043697 [patent_app_country] => US [patent_app_date] => 2011-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19917 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20110224229.pdf [firstpage_image] =>[orig_patent_app_number] => 13043697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9026580 [patent_doc_number] => 08536162 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-17 [patent_title] => 'Conjugates of 1,4,7-triazacyclononanes, dinuclear metal complexes of such conjugates, and methods of use for both 1,4,7-triazacyclononanes and conjugates' [patent_app_type] => utility [patent_app_number] => 13/044220 [patent_app_country] => US [patent_app_date] => 2011-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3729 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13044220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7501693 [patent_doc_number] => 20110263581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'FUSED TRICYCLIC COMPOUNDS AS SERINE-THREONINE PROTEIN KINASE AND PARP MODULATORS' [patent_app_type] => utility [patent_app_number] => 13/035640 [patent_app_country] => US [patent_app_date] => 2011-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 43241 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263581.pdf [firstpage_image] =>[orig_patent_app_number] => 13035640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064958 [patent_doc_number] => 20110201806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'Methods for Forming Protected Organoboronic Acids' [patent_app_type] => utility [patent_app_number] => 13/030833 [patent_app_country] => US [patent_app_date] => 2011-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17930 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201806.pdf [firstpage_image] =>[orig_patent_app_number] => 13030833 [rel_patent_id] =>[rel_patent_doc_number] =>)